Policy Issues in the Clinical Development and Use of Immunotherapy for Cancer Treatment

by National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Care Services, National Cancer Policy Forum, Sharyl J. Nass